Atherosclerotic cardiovascular disease (ASCVD) prevention has historically focused on controlling and treating traditional risk factors that are associated with adverse clinical events. 1, 2 This "high-risk" approach aims to reduce cardiovascular illness. However, it is increasingly recognized that ideal cardiovascular health cannot be achieved by just controlling ASCVD risk factors but also requires the active promotion of factors associated with health. 3 Thus, the potential virtues of an alternative prevention paradigmfocused on cardiovascular wellness-have recently come into focus. 4 This paradigm emphasizes the identification and promotion of modifiable behavioral and psychosocial factors that improve well-being and help to prevent or delay the onset of clinical disease. 5, 6 For example, the American Heart Association (AHA) has introduced the Life's Simple 7 (LS7) score to facilitate this effort. 3 Although reducing illness and promoting wellness are complementary activities, too often, health care providers concentrate on the former without giving due attention to the latter. 4, 7 Adults with advanced subclinical coronary atherosclerosis are at especially high risk for ASCVD events and are often highly motivated to improve their cardiovascular health. 8 For example, primary prevention adults without prior clinical ASCVD but with coronary artery calcium (CAC) N100 Agatston units have event rates similar to secondary prevention adults who have previously experienced an ASCVD event. 9 Indeed, analyses from observational cohorts, including the Multi-Ethnic Study of Atherosclerosis (MESA), 10 the Coronary Artery Risk Development in Young Adults Study, 11 and the Heinz Nixdorf Recall Study, 12 have consistently demonstrated that CAC is one of the strongest known predictors of incident ASCVD and death and provides additional prognostic information over and above traditional risk factors.
However, most adults with elevated CAC do not develop clinical ASCVD over near-to medium-term follow-up, and little is known about factors associated with the absence of incident events among these individuals. Identifying such health factors may elucidate targets that can be promoted to foster ideal cardiovascular health in this vulnerable population. This knowledge may also help health care providers counsel adults with elevated CAC on how to maintain cardiovascular wellness and avoid or delay clinical disease. Indirect evidence supports the existence of health factors in this setting, for example, some lifestyle factors appear to be inversely correlated with prevalence of CAC at baseline. 13 We therefore examined whether health factors are associated with lower risk and delay in onset of ASCVD or mortality among persons with elevated CAC at baseline. In accordance with the emerging concept of ideal cardiovascular health, 3 the factors examined encompass self-reported behaviors and psychosocial variables, as well as measured physiologic variables.
Methods

Study participants
MESA is a community-based cohort study of the prevalence, correlates, and progression of subclinical and clinical ASCVD. Details of the MESA study design and objectives are 
Inclusion/exclusion criteria
Our primary analytic sample included MESA participants with significant subclinical atherosclerosis, defined as CAC N100 at baseline. 9 We excluded individuals with missing information on events (n = 3).
CAC measurement
CAC was assessed at baseline using either electron-beam computed tomography (CT) (at the Chicago, Los Angeles, and New York centers) or multidetector CT (at the Baltimore, Forsyth County, and St Paul centers). Each participant was scanned twice, and all images were interpreted at a single CT reading center (the LA Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA). 13 The mean CAC score of the 2 scans was used. Intraobserver and interobserver agreements were excellent (κ statistics, 0.93 and 0.90, respectively), and the intraclass correlation coefficient for the Agatston score was 0.99. 10 
Study outcomes
The co-primary outcomes for this analysis were all-cause mortality and hard ASCVD, which included myocardial infarction, resuscitated cardiac arrest, CHD death, stroke, or stroke death. Secondary outcomes included all-cause ASCVD events, defined as hard ASCVD events in addition to definite angina, probable angina if followed by revascularization, other atherosclerotic death, or other CVD death. A full description of the adjudication process of events is described elsewhere.
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Measurement and definition of health factors
At the baseline examination, self-reported information was collected pertaining to demographics, marital status, medication use, family history, cigarette smoking, alcohol use, and sleep quality using standard and well-validated questionnaires. 14 
Self-reported behavioral health factors
Healthy smoking behavior was defined as absence of current cigarette smoking. 3 Healthy sleep pattern was defined as having b1 day of restless sleep in the past week. 15 Diet was assessed using a 120-item food frequency questionnaire (FFQ, with missing variables imputed using sequential chained regression, see online appendix). FFQ data were categorized based on a previously validated score quantifying adherence to the Mediterranean-style diet. 16 This resulted in a summary score ranging from 0 (poor adherence) to 11 (maximum adherence). Healthy diet was defined as having a Mediterranean-style diet score in the upper 25% of the cohort distribution.
The MESA Typical Week Physical Activity Survey was designed to identify the time spent in, and frequency of, various physical activities during a typical week in the past month. 16 Healthy physical activity was defined as being in the upper 25% of min/wk of moderate/vigorous physical activity of the cohort distribution. 17 
Self-reported psychosocial health factors
Other factors of potential interest to cardiovascular health include psychosocial variables such as emotional support, depression, and chronic stress burden. [18] [19] [20] [21] Emotional support was assessed using the ENRICHD Social Support Inventory, which consists of 6 questions pertaining to the availability of emotional support. Scores range from 6 to 30, and healthy emotional support was defined as a score of ≥25. 22 The presence of depressive symptoms was recorded using the Center for Epidemiologic Studies Depression Scale (CES-D). Scores range from 0 to 60, and absence of depression was defined as a CES-D score b16. 23 Chronic stress burden was assessed using the chronic burden scale, which measures ongoing difficulty in 5 life domains including personal health, health of a close contact, job, finances, and relationships lasting more than 6 months. Scores range from 0 to 5, and absence of chronic stress burden was defined as a score of 0. 24 
Measured health factors
Body mass index (BMI) was calculated as measured weight (kg) divided by measured height squared (m 2 ). Healthy BMI was defined as 18.5-24.9 kg/m 2 . Systolic and diastolic blood pressures (SBP and DBP, respectively) were measured 3 times using an automated sphygmomanometer (Dinamap, Critikon, Tampa, FL), and the mean of the last 2 measurements was used. Healthy blood pressure was defined as a SBP b120 mm Hg and a DBP b80 mm Hg. A central laboratory (University of Vermont, Burlington, VT) measured concentrations of total and high-density lipoprotein cholesterol (HDL-C), triglycerides, and plasma glucose after a 12-hour fast. Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation.
Healthy LDL-C was defined as LDL-C b 70 mg/dL. Healthy glucose was defined as b100 mg/dL. Healthy HDL-C was defined as HDL-C N 40 mg/dL for men and N50 mg/dL for women.
Other covariates
Hypertension was defined as SBP ≥140 mm Hg, DBP ≥90 mm Hg, or antihypertensive medication use. Diabetes mellitus was defined as a fasting glucose of ≥7 mmol/L (126 mg/dL) or use of hypoglycemic medication (oral agents and/or insulin). Family history of CHD was defined in MESA as the presence of a fatal or nonfatal myocardial infarction, coronary angioplasty, or coronary artery bypass surgery in any immediate family member (parent, sibling, or child). Medication use was updated at each MESA visit following baseline (visits 2 through 5).
Statistical analysis
Baseline characteristics were summarized using means (SD) or medians (interquartile range [IQR]) depending on normality of data for continuous variables, and using counts (percentage) for discrete variables. We used χ 2 tests for discrete variables and t tests or Kruskal-Wallis test for continuous variables, as appropriate, to test for differences between participants with or without hard ASCVD events over follow-up.
To study the inverse association between health factors and incident ASCVD and mortality, we constructed multivariable-adjusted Cox proportional hazards models. The proportionality assumption was confirmed using log-log plots. Model 1 was adjusted for demographic variables (age, sex, and race/ethnicity). Model 2 was adjusted for covariates in model 1 plus MESA site; education; occupational status; income; marital status; family history of CHD; presence of diabetes mellitus; presence of hypertension; and, for medications, time-varying use of statin, aspirin, glucose-lowering, and antihypertensive therapies. To evaluate for possible effect measure modification by sex or race/ethnicity, we performed multiplicative interaction testing with each health factor separately in our primary analytic sample of participants with baseline CAC N100. Similarly, we assessed for effect modification by CAC (≤100 vs N100) in the association of health factors and outcomes in the overall MESA study population. Analyses of diet were additionally adjusted for total caloric intake (kcal/d) to account for the known underreporting in FFQ data 25 and further excluded participants with implausible data defined as total caloric intake b600 kcal/d or N6000 kcal/d (n = 147).
To model the cumulative effect of these health factors, we assigned each MESA participant a score of 1 for the presence of each of the above health factors so as to derive a total "health factor" score by summing all 12 components (range 0-12). We also calculated the LS7 score for each participant 3 using definitions published by the AHA (Supplementary Table I ). Then, to evaluate for a graded ("dose-response") relationship between number of health factors and risk of events, unadjusted KaplanMeier survival curves by tertile of health factor score for incident hard ASCVD events and mortality were drawn. Tertiles included 0 to 4, 5 to 6, and 7 to 12 health factors. Hazard ratios (HRs) of events per 1-unit increase of these scores were also calculated, adjusting for covariates in model 2.
In a secondary analysis, we used an accelerated failure-time model to examine whether the health factors evaluated above were associated with event-free time gained among those MESA participants who did experience incident ASCVD or death. The accelerated failure time model estimates a time ratio whereby if a factor helps to delay the occurrence of events, the time ratio will be N1. For instance, a time ratio of 1.5 means that, among those who have an event, it takes on average 50% longer for an event to occur in persons with the health factor compared with those without the health factor. 26 To test the robustness of our results, we conducted the following sensitivity analyses: (1) we defined healthy blood pressure, glucose, and lipid levels using values achieved without medication use and based our definition of healthy diet and physical activity on AHA LS7 criteria; (2) we defined advanced subclinical atherosclerosis using different thresholds (CAC N75th percentile for age, sex, and race/ethnicity) (n = 1,667) and CAC N 400 (n = 675); (3) we directly modeled the outcome of being "event-free at administrative censoring" for both ASCVD and death using logistic regression models with assumption of no confounding by follow up time; and (4) we accounted for competing risk of non-ASCVD mortality using Fine and Gray models evaluating ASCVD outcomes.
A P value b .05 was considered statistically significant. All analyses were conducted using Stata version 13.1 (StataCorp, College Station, TX).
Results
Study cohort
The study population consisted of 1,601 MESA participants. The mean (±SD) age was 69 (±9) years, 64% were males, 49% were white, 22% African American, 18% Hispanic, and 10% Chinese. The median (IQR: 25th-75th percentile) baseline CAC was 332 (177-677) Agatston units. Baseline characteristics, overall and according to presence of incident hard ASCVD events during follow-up, are summarized in Table I . Compared with individuals who developed incident ASCVD events, those who remained free of ASCVD at end of follow-up were on average younger and less likely to be hypertensive, be diabetic, and smoke cigarettes. They also tended to engage in more moderate/vigorous physical activity and had higher HDL-C (all Ps b .05).
Association of health factors with incident ASCVD and mortality
After a median (IQR) follow-up of 12.1 (11.5-12.7) years, 276 individuals with baseline CAC N100 experienced hard ASCVD events (incidence rate = 17.7 per 1000 person-years), and 443 died (mortality rate = 25.4 per 1000 person-years). To provide perspective on the lower absolute and relative risk of events associated with each health factor (compared with the absence of this health factor), incidence rates and HRs are reported in Table II . After multivariable adjustment, absence of current smoking, healthy HDL-C levels, and low stress burden remained statistically significant inverse predictors of ASCVD (HRs ranging from 0.58 to 0.71) (Table II) . With respect to mortality, absence of current smoking, healthy glucose, regular physical activity, and absence of chronic stress burden were inversely associated with death in the multivariable-adjusted model (HRs ranging from 0.40 to 0.77), whereas LDL-C b 70 mg/dL appeared to be directly associated with mortality (HR = 1.57) (all Ps b .05) (Table II) . Emotional support; absence of depression; and, to a lesser extent, Mediterranean diet also appeared protective for mortality, although multivariable-adjusted models failed to reach significance. Defining healthy physical activity and diet based on AHA LS7 criteria led to similar results.
For both outcomes, there were no significant interactions with sex or race/ethnicity. There was also no consistent interaction between any health factor and CAC level. Defining health factors (blood pressure, LDL-C, HDL-C, glucose) based on values among untreated participants only yielded nearly identical results except that healthy HDL-C and LDL-C b 70 were no longer significantly associated with hard ASCVD and mortality, respectively (Supplementary Table II) .
Results for the ASCVD outcome were similar in analyses accounting for competing risk from non-cardiovascular--related death; however, availability of emotional support was also shown to have an inverse association in this model (Supplementary Table III) . Logistic regression analyses directly modeling of the outcome of being "event free" for hard ASCVD and mortality were also qualitatively similar but with absence of depression significantly associated with reduced mortality in multivariate analyses (Supplementary Table IV ). The corresponding HRs for each of these health factors among participants with various cutoffs for elevated CAC (eg, N400 and N75th percentile) are presented in Supplementary Tables V (for mortality) and VI (for ASCVD).
Accelerated failure time models
After multivariable adjustment, participants who were noncurrent smokers took on average 68% longer to develop incident ASCVD (time ratio 1.68), whereas the corresponding time ratios for HDL-C and absence of chronic stress burden were 1.54 and 1.41, respectively (all Ps b .05) (Table III) . For death, absence of current smoking, healthy glucose, adequate levels of physical activity, absence of depression, and absence of chronic stress were all associated with a relative delay in the occurrence of this outcome (Table III) .
Healthy lifestyle scores Figure 1 shows the unadjusted Kaplan-Meier survival curves for (a) incident hard ASCVD and (b) mortality, according to tertiles of the health factor score. Each 1-unit increase in the health factor score was associated with an 11% lower risk of both hard ASCVD (95% CI 2%-19%) and mortality (95% CI 5%-18%). A 1-unit increase in the LS7 score was associated with a 9% lower risk of mortality (95% CI 0.01%-17%), but results for ASCVD were not significant.
Discussion
The current study demonstrates modifiable health factors that are associated with lower risk and delay in onset of ASCVD or death among individuals with subclinical atherosclerosis as determined by elevated CAC. Specifically, nonsmoking, adequate physical activity, absence of chronic stress, high HDL-C levels, and normoglycemia were inversely associated with risk of hard ASCVD events and/or death. There were also favorable trends for Mediterranean diet, emotional support, and absence of depression. Importantly, there was a graded association between health factors and lower risk of events in persons with elevated CAC. These factors were also associated with a relative time delay in disease onset among those who experienced clinical events. The novel accelerated failure time models used in this analysis are important in that they present the potential preventive impact of health factors from a vertical (ie, how long is health maintained among persons who do have an event? [also termed compression of morbidity]) 27 rather than just a horizontal (ie, do a lower proportion of persons with a given health factor have an event than those without that health factor?) perspective. Consequently, these models can illustrate the potential importance of health factors in maintaining duration of wellness, a critical societal and economic issue.
Nonsmoking was the health factor most strongly associated with relative risk reduction for both ASCVD and all-cause mortality. After adjusting for time-varying statin use, optimal levels of LDL-C appeared to be associated with higher risk of mortality in our study. The cholesterol paradox has been previously described among high-CVD risk individuals and persons with chronic illnesses. 28 This phenomenon may reflect reverse causality. For example, the highest-risk patients are often more likely to receive potent statins and thereby achieve low LDL-C. In keeping with this, among statin-untreated individuals in this MESA analysis, LDL-C was no longer a significant predictor of mortality. Furthermore, healthy BMI was not a significant inverse predictor of incident outcomes in our analysis. Indeed, the predictive value of BMI in high-risk individuals with CAC N 100 may be less important compared with the general population.
We believe that our results have implications for the primary prevention of ASCVD in vulnerable high-risk adults with subclinical atherosclerosis. Extrapolating from the MESA study database, up to 25% of the Western adult populations could have CAC N100. 10 Whether CAC imaging deserves a larger role in ASCVD prevention is outside the scope of this discussion; however, it is clear that the likelihood of future events is higher when elevated CAC is combined with uncontrolled traditional risk factors. 29 Based on this, most contemporary prevention efforts in persons with elevated CAC are aimed at aggressively treating these risk factors. However, these individuals may further benefit from a strategy focused on promoting cardiovascular health by cultivating health factors. Supporting such a strategy, we demonstrate, to our knowledge for the first time, the presence of health factors that are inversely associated with events among this important population of high-risk primary prevention adults, and that these health factors are independent of treated risk factors. Log-rank test P < .001
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A, Kaplan-Meier survival estimates of incident hard ASCVD events by tertile of health factor score. B, Kaplan-Meier survival estimates of incident mortality events by tertile of health factor score.
It is worth emphasizing that ASCVD health factors are not always simply the inverse of ASCVD risk factors. First, some health factors do not have an obvious contrasting risk factor. For instance, the converse of a Mediterranean diet is not readily and consistently identifiable (eg, Western diet, high-fat diet, high-carbohydrate diet, or other?). Second, some health factors (eg, diet and exercise) could protect individuals from ASCVD via mechanisms that are different from those by which risk factors predispose to harm. Third, the presence of a well-controlled risk factor (eg, LDL-C b 100 mg/dL or SBP ≤ 140 mm Hg) may represent a lower bar than the achievement of a health factor (eg, LDL b 70 mg/dL or SBP ≤ 120 mm Hg). Fourth, the distinction between health factors and risk factors may be especially relevant in clinical practice when considered from a psychological and motivational perspective. Specifically, doctors often counsel their patients using a "risk-averse" perspective (eg, "stop smoking or you will have a heart attack") rather than using a "reward-seeking" one (eg, "nonsmokers live longer and healthier lives"). 30 A number of salient results from this analysis are worth highlighting. First, our Kaplan-Meier survival curves demonstrate marked prognostic heterogeneity among individuals with elevated CAC, according to the presence and number of health factors assessed at the baseline visit. Second, our cumulative health factor score demonstrated an inverse relationship with risk of ASCVD and mortality, a motivating finding given the known interrelatedness of many of these factors (eg, exercise is associated with less depression and increased psychological well-being).
Third, after accounting for time-varying use of preventive medication, optimal levels of blood pressure and LDL-C were not independently associated with lower risk of events. The apparent lack of relative health benefit for persons with these specific health factors could be explained by the initiation or intensification of contemporary preventive medication use (eg, statin and antihypertensive drugs) among persons with suboptimal levels of these parameters at the baseline visit (we modeled time-varying medication use in our analysis). However, precisely because our analysis adjusted for baseline and subsequent use of statin and antihypertensive drugs, we do not believe that our results contradict the importance of treating traditional risk factors where necessary.
Taken together, these results should be of interest and assistance to providers who counsel patients with occult atherosclerosis-who are often highly motivated to improve their cardiovascular health but in whom uncertainty often exists as to the optimal prevention strategy.
Limitations
Our study has limitations. (1) This is an observational study, and thus, causality can be suggested but not established. (2) Results of the CAC score were made available to participants and their physicians, which may have altered prescription patterns of preventive pharmacotherapy over follow-up that could influence cardiovascular event rates. However, we attempted to account for this by adjusting for time-varying use of such medications. Furthermore, knowledge of CAC scores may also have influenced subsequent lifestyle behavior of participants, 8 thereby attenuating some of our findings. (3) The behavioral and psychosocial factors considered in this study were self-reported and may not necessarily reflect all meaningful determinants of health. Moreover, the definition of these health factors is limited based on the available information in MESA. (4) We used a derived summative healthy lifestyle score that assigns the same weight to each health factor when in fact this may not be true. This score was designed to test the cumulative effect of known health factors on wellness and was not designed, derived, or validated for use as a prediction tool in clinical practice. (5) Finally, our study also highlights the inherent limitations of current cardiovascular epidemiology cohorts in studying wellness-a major gap in knowledge. For example, no participant-reported (or other) prospective wellness outcomes are available in the MESA data set, requiring us to model the absence of disease as a proxy for health even though these are not one and the same.
In conclusion, modifiable health factors are associated with lower risk and delay in onset of clinical ASCVD or death among individuals with elevated CAC. Furthermore, a higher number of these health factors is associated with a lower risk of events, motivating a multifaceted and holistic approach to preventing clinical ASCVD among adults with subclinical atherosclerosis.
Summary statement
The presence of high CAC does not predetermine the development of clinical CVD, and this analysis demonstrates that adults with subclinical atherosclerosis have behavioral and psychosocial options to improve their prognosis over and above standard preventive therapies such as aspirin and statins.
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